摘要:
The present invention concerns a dual emitting hybrid organic-inorganic material. More particularly it relates to a luminescent material made of a polymer-matrix comprising a luminescent organic compounds and luminescent metal cluster compounds.
摘要:
The invention relates to a ruthenium alkylidene complex comprising a 1-aryl-3-cycloalkyl-imidazolin-2-ylidene ligand, the cycloalkyl group of said 1-aryl-3-cycloalkyl-imidazolin-2-ylidene ligand being a cyclic secondary aliphatic alkyl.
摘要:
The present invention relates to metal alkylidene complex comprising a 1-aryl-3-alkyl-imidazol-2-ylidene ligand, wherein the aryl group of said 1-aryl-3-alkyl-imidazol-2-ylidene ligand is an aromatic and wherein the alkyl group of said 1-aryl-3-alkyl-imidazol-2-ylidene ligand is selected from the group consisting of a cyclic secondary aliphatic alkyl and a C 2 -C 10 -heteroalkyl, and wherein said metal is selected from the group consisting of Pd, Ag, Au, Ir, Rh, Cu, Ni, Mg, Zn, Ti, Pt and Fe, with the provision that the aryl group of said 1-aryl-3-alkyl-imidazol-2-ylidene ligand is other than an ortho-hydroxyaryl group when said metal is Pd and when said cyclic secondary aliphatic alkyl is cyclohexyl.
摘要:
Liver cancer in humans is the fifth most common cancer in the world. Chemoembolization is an alternative strategy to surgery and radiotherapy that is attractive due to the effectiveness thereof and the limitation of side-effects for the patient. Formulations according to prior art have problems of stability and effectiveness which limit the clinical use thereof. The present invention therefore relates to a composition for treating liver cancer in humans including a complex of the following formula (I): [M(RCS3)2(RCS2)] where M is 188Re with high activity, that is to say greater than 3.7 Gbq, and a lipophilic organic base emulsified with an aqueous phase, R is an alkyl, cycloalkyl or aryl group, unsubstituted or substituted with one or more substituents selected from among halogen atoms, a hydroxyl group, alkyl groups and alkoxy groups.